[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

World DNA Sequencing Market to See Impressive CAGR of almost 30% to 2022

06 Feb 2018 • by Natalie Aster

LONDON – DNA sequencing refers to any technique or technology utilised to detect the precise sequence of nucleotides within a deoxyribonucleic acid (DNA) molecule. The nucleotide sequence is the most underlying level of knowledge of a gene or the whole genome. It is the blueprint that includes all the information necessary for building and maintaining an organism, and it is inconceivable to fully understand genetic function or evolution without acquiring this information. Nowadays, with the use of proper cutting-edge equipment and materials, sequencing a short speck of DNA is comparatively straightforward.

The latest set of DNA sequencing technologies, which are collectively known as next-generation (highly parallel, second-generation) sequencing have predominantly pushed out first-generation sequencing technologies created back in the 1970s. Supported by the advancements in bioinformatics, these more novel approaches allow many DNA fragments to be sequenced simultaneously, and they are also much more rapid and cost-efficient as against first-generation technologies. 

From 2018 until 2022, the world’s DNA sequencing market is set to gain traction, posting a remarkable CAGR of 20.93%. The all-inclusive cost structure of sequencing products is deemed to be boosting the demand for DNA sequencing in the next-gen sequencing space. Manufacturers hammed out an all-inclusive cost method, including the cost of various components, direct expenses, and indirect costs. This all-inclusive cost structure sets out the structure of costs to end customers and financing agencies. Additionally, this cost method decreases the volume of sequencing and increments the amount of data. Granular cost-related information reduces the cost of sequencing and that augments the amounts of genome data for improved research.

Top Trends in DNA Sequencing Market

The most recent trend shaping the marketplace includes the emergence of the various bioinformatics tools that contribute to easier DNA sequencing. DNA sequencing companies are taking actions to enhance the realizability and affordability of DNA sequencing. Owing to this, the next-gen sequencing market is observing the development of time-effective, cost-efficient advanced products. The uptake of cost-effective and easy-to-use bioinformatic tools for DNA sequence analysis is also likely to fuel the sector’s growth.

Key Challenges of DNA Sequencing Market

Meantime, the market growth can be significantly obstructed by difficulties associated with clinical interpretations and poor reimbursements. Challenges pertaining to clinical samples are expected to affect the market growth. A specific exome sample can incorporate up to 20,000 variants, whilst a whole-genome sample will typically have over 3 million. Therefore, a patient may have to get multiple genetic tests done before the pathogenic mutation is detected, and this can become inconvenient and budget-unfriendly for the patient.

New Reports on DNA Sequencing Market Available at MarketPublishers.com:


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest